Literature DB >> 12822917

Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations.

Peter D Friedmann1, Stephenie C Lemon, Michael D Stein, Thomas A D'Aunno.   

Abstract

OBJECTIVES: This study examined organization-level characteristics associated with the accessibility of outpatient addiction treatment.
METHODS: Program directors and clinical supervisors from a nationally representative panel of outpatient substance abuse treatment units in the United States were surveyed in 1990, 1995, and 2000. Accessibility was measured from clinical supervisors' reports of whether the treatment organization provided "treatment on demand" (an average wait time of 48 hours or less for treatment entry), and of whether the program turned away any patients.
RESULTS: In multivariable logistic models, provision of "treatment on demand" increased two-fold from 1990 to 2000 (OR, 1.95; 95 percent CI, 1.5 to 2.6), while reports of turning patients away decreased nonsignificantly. Private for-profit units were twice as likely to provide "treatment on demand" (OR, 2.2; 95 percent CI, 1.3 to 3.6), but seven times more likely to turn patients away (OR, 7.4; 95 percent CI, 3.2 to 17.5) than public programs. Conversely, units that served more indigent populations were less likely to provide "treatment on demand" or to turn patients away. Methadone maintenance programs were also less likely to offer "treatment on demand" (OR, .65; 95 percent CI, .42 to .99), but more likely to turn patients away (OR, 2.4; 95 percent CI, 1.4 to 4.3).
CONCLUSIONS: Although the provision of timely addiction treatment appears to have increased throughout the 1990s, accessibility problems persist in programs that care for indigent patients and in methadone maintenance programs.

Entities:  

Mesh:

Year:  2003        PMID: 12822917      PMCID: PMC1360921          DOI: 10.1111/1475-6773.00151

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  35 in total

1.  Trends in mental health services use and spending, 1987-1996.

Authors:  S H Zuvekas
Journal:  Health Aff (Millwood)       Date:  2001 Mar-Apr       Impact factor: 6.301

2.  The challenge of managed care in drug abuse treatment.

Authors:  J Guydish; R Muck
Journal:  J Psychoactive Drugs       Date:  1999 Jul-Sep

3.  Drug abuse treatment on demand in San Francisco: preliminary findings.

Authors:  J Guydish; L Moore; A Gleghorn; T Davis; C Sears; J Harcourt
Journal:  J Psychoactive Drugs       Date:  2000 Oct-Dec

Review 4.  Rethinking access to alcohol treatment.

Authors:  C Weisner; L A Schmidt
Journal:  Recent Dev Alcohol       Date:  2001

5.  A new era in opioid dependency treatment. Recent law allows qualified physicians to provide care in office setting.

Authors:  H W Clark
Journal:  Postgrad Med       Date:  2001-06       Impact factor: 3.840

6.  Attrition prevention with individuals awaiting publicly funded drug treatment.

Authors:  D M Donovan; D B Rosengren; L Downey; G B Cox; K L Sloan
Journal:  Addiction       Date:  2001-08       Impact factor: 6.526

Review 7.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

8.  Access to substance abuse treatment services under the Oregon Health Plan.

Authors:  D D Deck; B H McFarland; J M Titus; K E Laws; R M Gabriel
Journal:  JAMA       Date:  2000-10-25       Impact factor: 56.272

9.  Private and public ownership in outpatient substance abuse treatment: do we have a two-tiered system?

Authors:  J R Wheeler; T A Nahra
Journal:  Adm Policy Ment Health       Date:  2000-03

10.  The impact of managed care on substance abuse treatment: a report of the American Society of Addiction Medicine.

Authors:  M Galanter; D S Keller; H Dermatis; S Egelko
Journal:  J Addict Dis       Date:  2000
View more
  30 in total

1.  Factors related to Medicaid payment acceptance at outpatient substance abuse treatment programs.

Authors:  Yvonne M Terry-McElrath; Jamie F Chriqui; Duane C McBride
Journal:  Health Serv Res       Date:  2010-11-24       Impact factor: 3.402

2.  Does the impact of managed care on substance abuse treatment services vary by provider profit status?

Authors:  Todd A Olmstead; Jody L Sindelar
Journal:  Health Serv Res       Date:  2005-12       Impact factor: 3.402

3.  Impact of California's Proposition 36 on the drug treatment system: treatment capacity and displacement.

Authors:  Yih-Ing Hser; Cheryl Teruya; Alison H Brown; David Huang; Elizabeth Evans; M Douglas Anglin
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

4.  Individual and system influences on waiting time for substance abuse treatment.

Authors:  Carey J A Carr; Jiangmin Xu; Cristina Redko; D Timothy Lane; Richard C Rapp; John Goris; Robert G Carlson
Journal:  J Subst Abuse Treat       Date:  2007-05-23

5.  Interim treatment: Bridging delays to opioid treatment access.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2015-04-30       Impact factor: 4.018

6.  Waiting Time as a Barrier to Treatment Entry: Perceptions of Substance Users.

Authors:  Cristina Redko; Richard C Rapp; Robert G Carlson
Journal:  J Drug Issues       Date:  2006-09

7.  Dropout from interim methadone and subsequent comprehensive methadone maintenance.

Authors:  Jan Gryczysnki; Robert Schwartz; Kevin O'Grady; Jerome Jaffe
Journal:  Am J Drug Alcohol Abuse       Date:  2009-12-15       Impact factor: 3.829

8.  Challenges in motivating treatment enrollment in community syringe exchange participants.

Authors:  Michael Kidorf; Elizabeth Disney; Van King; Ken Kolodner; Peter Beilenson; Robert K Brooner
Journal:  J Urban Health       Date:  2005-07-13       Impact factor: 3.671

9.  Effect of quality chronic disease management for alcohol and drug dependence on addiction outcomes.

Authors:  Theresa W Kim; Richard Saitz; Debbie M Cheng; Michael R Winter; Julie Witas; Jeffrey H Samet
Journal:  J Subst Abuse Treat       Date:  2012-07-25

10.  Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.

Authors:  Stacey C Sigmon; Andrew C Meyer; Bryce Hruska; Taylor Ochalek; Gail Rose; Gary J Badger; John R Brooklyn; Sarah H Heil; Stephen T Higgins; Brent A Moore; Robert P Schwartz
Journal:  Addict Behav       Date:  2015-07-29       Impact factor: 3.913

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.